Genomic correlates and classification of PD-L1 status in non-small cell lung cancer.

被引：0
|
作者：
Liang, Feng
Liu, Sisi
Jiang, Ya
Xu, Xiuxiu
Ou, Qiuxiang
Bao, Hua
Wu, Xue
Shao, Yang
Hu, Xingsheng
机构：
[1] Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China
[2] Nanjing Geneseeq Technol Inc, Nanjing, Peoples R China
[3] Geneseeq Technol Inc, Translat Med Res Inst, Toronto, ON, Canada
[4] Nanjing Geneseeq Technol, Toronto, ON, Canada
[5] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Natl Canc Ctr, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21578
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PD-L1 immunohistochemistry in patients with non-small cell lung cancer
    Jotatsu, Takanobu
    Oda, Keishi
    Yatera, Kazuhiro
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S2127 - S2129
  • [22] Significance of the Expression of PD-L1/PD-1 by Tumoral and Immune Cells in Non-Small Cell Lung Cancer.
    Ortiz-Villalon, C.
    De Petris, L.
    Kis, L.
    Yoshikawa, A.
    Ngoc, H.
    Roden, A.
    Fukuoka, J.
    Montero, A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S948 - S948
  • [23] Higher PD-L1 expression correlates with lymphocyte infiltration in early non-small cell lung cancer
    Rocha, P.
    Rodrigo, M.
    Moliner, L.
    Hardy-Werbin, M.
    Casadevall Aguilar, D.
    Duran, X.
    Arpi, O.
    Clave, S.
    Salido, M.
    Riera, X.
    Menendez, S.
    Taus, A.
    Pijuan, L.
    Comerma, L.
    Arriola Aperribay, E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [24] Measurement of spatial and antibody-based PD-L1 heterogeneity in non-small cell lung cancer.
    Gaule, Patricia
    Rehman, Jamaal
    Smithy, James William
    Toki, Maria
    Han, Gang
    Neumeister, Veronique
    Carvajal-Hausdorf, Daniel E.
    Schalper, Kurt Alex
    Pelekanou, Vasiliki
    Wasserman, Brad
    Herbst, Roy S.
    Rimm, David L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [25] PD-1 and PD-L1 inhibitor toxicities in non-small cell lung cancer
    Shankar, Bairavi
    Naidoo, Jarushka
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S4034 - S4037
  • [26] Targeting the PD-1/PD-L1 axis in non-small cell lung cancer
    Kumar, Rajiv
    Collins, Dearbhaile
    Dolly, Saoirse
    McDonald, Fiona
    O'Brien, Mary E. R.
    Yap, Timothy A.
    CURRENT PROBLEMS IN CANCER, 2017, 41 (02) : 111 - 124
  • [27] Research progression of PD-1/PD-L1 in non-small cell lung cancer
    Xing Liu
    Xiaodong Xie
    Oncology and Translational Medicine, 2017, 3 (03) : 111 - 115
  • [28] PD-L1 expression in different samples of non-small cell lung cancer
    Kovacevic, M.
    Kern, I.
    VIRCHOWS ARCHIV, 2017, 471 : S104 - S104
  • [29] PD-L1, PD-1, and CTLA-4 as prognostic biomarkers in resected non-small cell lung cancer.
    Owonikoko, Taofeek Kunle
    Kowalski, Jeanne
    Kim, Sungjin
    Dwivedi, Bhakti
    Chen, Zhengjia
    Behera, Madhusmita
    Mayfield, William
    Hermann, Robert C.
    Chen, Lieping
    Khuri, Fadlo Raja
    Ramalingam, Suresh S.
    Sica, Gabriel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] Current status and progress of PD-L1 detection: guiding immunotherapy for non-small cell lung cancer
    Qi, Chang
    Li, Yalun
    Zeng, Hao
    Wei, Qi
    Tan, Sihan
    Zhang, Yuanyuan
    Li, Weimin
    Tian, Panwen
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
12345